Related Experiment Video

Updated: Jul 1, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

LRRK2 R1628P increases risk of Parkinson's disease: replication evidence

E K Tan1, Louis C Tan, H Q Lim

  • 1Department of Neurology, Singapore General Hospital, National Neuroscience Institute, Outram Road, Singapore, 169608, Singapore. gnrtek@sgh.com.sg

Human Genetics
|September 11, 2008
PubMed

Insights

A specific LRRK2 gene variant, R1628P, is more common in individuals with Parkinson's disease (PD). This finding suggests R1628P increases the risk of developing PD, particularly in the Chinese population.

Area of Science:

  • Genetics
  • Neurodegenerative Diseases
  • Human Health

Background:

  • Parkinson's disease (PD) is a progressive neurodegenerative disorder.
  • Genetic factors play a significant role in PD etiology.
  • LRRK2 gene mutations are a known cause of familial and sporadic PD.

Purpose of the Study:

  • To investigate the association between the LRRK2 R1628P variant and Parkinson's disease risk in a Chinese population.
  • To confirm the role of the R1628P variant in PD pathogenesis.

Main Methods:

  • Case-control study comparing the frequency of the LRRK2 R1628P variant in PD patients and healthy controls.
  • Genotyping of the LRRK2 c.4883G > C (R1628P) variant.
  • Multivariate logistic regression analysis adjusting for age, age of onset, and gender.

Main Results:

  • The frequency of the LRRK2 R1628P variant was significantly higher in Parkinson's disease patients (8.4%) compared to controls (3.4%).
  • The heterozygous R1628P genotype was independently associated with an increased risk of PD (OR 3.3, 95% CI 1.4-7.9, P = 0.007) after adjusting for covariates.
  • This study provides independent confirmation of the R1628P variant's role in increasing PD risk.

Conclusions:

  • The LRRK2 R1628P variant is a risk factor for Parkinson's disease in the Chinese population.
  • Genetic screening for LRRK2 variants may aid in understanding PD heterogeneity.
  • Further research is warranted to elucidate the functional mechanisms of R1628P in PD pathogenesis.

More Related Videos

Assaying the Kinase Activity of LRRK2 in vitro06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...